HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Delays Green Chemistry Regulation Due To Widespread Discontent

This article was originally published in The Rose Sheet

Executive Summary

Due to “substantive and valid concerns” from industry, environmental groups, scientists and legislators, California’s Environmental Protection Agency and Department of Toxic Substances Control have decided to delay enactment of a regulation that could lead to reformulation of many personal-care products.

You may also be interested in...



Personal Care Will Be California Green Chemistry “Test Case” – Council

California’s Department of Toxic Substances Control is likely to target personal care with the next iteration of the Regulation for Safer Consumer Products enactment of which has been delayed due to widespread stakeholder concerns.

Personal Care Will Be California Green Chemistry “Test Case” – Council

California’s Department of Toxic Substances Control is likely to target personal care with the next iteration of the Regulation for Safer Consumer Products enactment of which has been delayed due to widespread stakeholder concerns.

Revised California Consumer Product Regulation Targets Personal Care

Under new revisions to California’s Regulation for Safer Consumer Products, personal-care products would be among the first goods to undergo evaluation for hazardous chemicals, which could require reformulation of products sold in the state.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel